Estimates Revisions Kobayashi Pharmaceutical Co., Ltd. Boerse Muenchen
Stocks
KOY
JP3301100008
Personal Products
|
Market Closed -
Boerse Muenchen
16:44:06 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 37.60 EUR | -4.08% |
|
+22.50% | +37.06% |
| 09-24 | Kobayashi Pharmaceutical Says No Decision Made on Potential Take-Private Deal by NSSK, CVC Capital Partners | MT |
| 09-24 | Kobayashi Reportedly in ¥500 Billion Buyout Talks After Red-Yeast Case | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Kobayashi Pharmaceutical Co., Ltd.(4967)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Kobayashi Pharmaceutical Co., Ltd.(4967)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Kobayashi Pharmaceutical Co., Ltd.(4967)
EBIT
Dividend / Share (DPS)
Data source:
Kobayashi Pharmaceutical Co., Ltd.(4967)
Cash or Net Debt
- Stock Market
- Stocks
- 4967 Stock
- KOY Stock
- Consensus Kobayashi Pharmaceutical Co., Ltd.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
